Apolipoprotein D: An overview of its role in aging and age-related diseases

Cell Cycle

Volumn 9, Issue 2, 2010, Pages 269-273

  Muffat, Julien ^a,c   Walker, David W ^b  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Aging; ApoD; Cancer; Drosophila; GLaz; NLaz; p53

Indexed keywords

APOLIPOPROTEIN D; ARACHIDONIC ACID; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; ESTROGEN; GLUCOCORTICOID; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPOCALIN; PROGESTERONE; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RETINOL; SOMATOMEDIN; VITAMIN D;

AGING; ALZHEIMER DISEASE; BIPOLAR DISORDER; GENE ACTIVITY; GENE EXPRESSION; HUMAN; LONGEVITY; MENTAL DISEASE; MOLECULAR BIOLOGY; MULTIPLE SCLEROSIS; NEOPLASM; NERVE INJURY; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SCHIZOPHRENIA; STROKE;

EID: 74949122722     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.2.10433     Document Type: Review

References (66)

1. Anderson D, Brenner S. Obituary: Seymour Benzer (1921-2007). Nature 2008; 451:139.
2. Dudai Y. Seymour Benzer (1921-2007). Neuron 2008; 57:24-6.
3. Greenspan RJ. Seymour Benzer (1921-2007). Curr Biol 2008; 18:106-10.
4. Jan YN, Jan L. Retrospective: Seymour Benzer (1921-2007). Science 2008; 319:45.
5. Tanouye MA. Seymour Benzer 1921-2007. Nat Genet 2008; 40:121.
6. McConathy WJ, Alaupovic P. Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system. FEBS Lett 1973; 37:178-82.
7. Drayna D, Fielding C, McLean J, Baer B, Castro G, Chen E, et al. Cloning and expression of human apolipoprotein D cDNA. J Biol Chem 1986; 261:16535-9.
8. Sanchez D, Ganfornina MD, Gutierrez G, Marin A. Exon-intron structure and evolution of the Lipocalin gene family. Mol Biol Evol 2003; 20:775-83.
9. Lambert J, Provost PR, Marcel YL, Rassart E. Structure of the human apolipoprotein D gene promoter region. Biochim Biophys Acta 1993; 1172:190-2.
10. Do Carmo S, Seguin D, Milne R, Rassart E. Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter. J Biol Chem 2002; 277:5514-23.
11. Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, Terrisse L, et al. Apolipoprotein D. Biochim Biophys Acta 2000; 1482:185-98.
12. Hu CY, Ong WY, Sundaram RK, Chan C, Patel SC. Immunocytochemical localization of apolipoprotein D in oligodendrocyte precursor-like cells, perivascular cells, and pericytes in the human cerebral cortex. J Neurocytol 2001; 30:209-18.
13. Eichinger A, Nasreen A, Kim HJ, Skerra A. Structural insight into the dual ligand specificity and mode of high density lipoprotein association of apolipoprotein D. J Biol Chem 2007; 282:31068-75.
14. Nasreen A, Vogt M, Kim HJ, Eichinger A, Skerra A. Solubility engineering and crystallization of human apolipoprotein D. Protein Sci 2006; 15:190-9.
15. Morais Cabral JH, Atkins GL, Sanchez LM, Lopez-Boado YS, Lopez-Otin C, Sawyer L. Arachidonic acid binds to apolipoprotein D: implications for the protein's function. FEBS Lett 1995; 366:53-6.
16. Vogt M, Skerra A. Bacterially produced apolipoprotein D binds progesterone and arachidonic acid, but not bilirubin or E-3M2H. J Mol Recognit 2001; 14:79-86.
17. Andersen JK. Oxidative stress in neurodegeneration: cause or consequence? Nat Med 2004; 10:18-25.
18. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005; 39:359-407.
19. Ordonez C, Navarro A, Perez C, Astudillo A, Martinez E, Tolivia J. Apolipoprotein D expression in substantia nigra of Parkinson disease. Histol Histopathol 2006; 21:361-6.
20. Kalman J, McConathy W, Araoz C, Kasa P, Lacko AG. Apolipoprotein D in the aging brain and in Alzheimer's dementia. Neurol Res 2000; 22:330-6.
21. Terrisse L, Poirier J, Bertrand P, Merched A, Visvikis S, Siest G, et al. Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. J Neurochem 1998; 71:1643-50.
22. Desai PP, Hendrie HC, Evans RM, Murrell JR, DeKosky ST, Kamboh MI. Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African-Americans. Am J Med Genet B Neuropsychiatr Genet 2003; 116:98-101.
23. Desai PP, Bunker CH, Ukoli FA, Kamboh MI. Genetic variation in the apolipoprotein D gene among African blacks and its significance in lipid metabolism. Atherosclerosis 2002; 163:329-38.
24. Helisalmi S, Hiltunen M, Vepsalainen S, Iivonen S, Corder EH, Lehtovirta M, et al. Genetic variation in apolipoprotein D and Alzheimer's disease. J Neurol 2004; 251:951-7.
25. Reindl M, Knipping G, Wicher I, Dilitz E, Egg R, Deisenhammer F, et al. Increased intrathecal production of apolipoprotein D in multiple sclerosis. J Neuroimmunol 2001; 119:327-32.
26. Boyles JK, Notterpek LM, Anderson LJ. Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E and apolipoprotein A-I. J Biol Chem 1990; 265:17805-15.
27. Rickhag M, Deierborg T, Patel S, Ruscher K, Wieloch T. Apolipoprotein D is elevated in oligodendrocytes in the peri-infarct region after experimental stroke: influence of enriched environment. J Cereb Blood Flow Metab 2008; 28:551-62.
28. Rickhag M, Wieloch T, Gido G, Elmer E, Krogh M, Murray J, et al. Comprehensive regional and temporal gene expression profiling of the rat brain during the first 24 h after experimental stroke identifies dynamic ischemia-induced gene expression patterns, and reveals a biphasic activation of genes in surviving tissue. J Neurochem 2006; 96:14-29.
29. Thomas EA, Copolov DL, Sutcliffe JG. From pharmacotherapy to pathophysiology: emerging mechanisms of apolipoprotein D in psychiatric disorders. Curr Mol Med 2003; 3:408-18.
30. Thomas EA, Dean B, Pavey G, Sutcliffe JG. Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders. Proc Natl Acad Sci USA 2001; 98:4066-71.
31. Mahadik SP, Khan MM, Evans DR, Parikh VV. Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome. Schizophr Res 2002; 58:55-62.
32. Thomas EA, Dean B, Scarr E, Copolov D, Sutcliffe JG. Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder. Mol Psychiatry 2003; 8:167-75.
33. Yao JK, Thomas EA, Reddy RD, Keshavan MS. Association of plasma apolipoproteins D with RBC membrane arachidonic acid levels in schizophrenia. Schizophr Res 2005; 72:259-66.
34. Thomas EA, George RC, Danielson PE, Nelson PA, Warren AJ, Lo D, et al. Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins. Mol Psychiatry 2003; 8:983-93.
35. Doane AS, Danso M, Lal P, Donaton M, Zhang L, Hudis C, et al. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene 2006; 25:3994-4008.
36. Hunter S, Weiss S, Ou CY, Jaye D, Young A, Wilcox J, et al. Apolipoprotein D is downregulated during malignant transformation of neurofibromas. Hum Pathol 2005; 36:987-93.
37. Hunter SB, Varma V, Shehata B, Nolen JD, Cohen C, Olson JJ, et al. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem 2005; 53:963-9.
38. Jin D, El-Tanani M, Campbell FC. Identification of apolipoprotein D as a novel inhibitor of osteopontininduced neoplastic transformation. Int J Oncol 2006; 29:1591-9.
39. Sugimoto K, Simard J, Haagensen DE, Labrie F. Inverse relationships between cell proliferation and basal or androgen-stimulated apolipoprotein D secretion in LNCaP human prostate cancer cells. J Steroid Biochem Mol Biol 1994; 51:167-74.
40. Lopez-Boado YS, Puente XS, Alvarez S, Tolivia J, Binderup L, Lopez-Otin C. Growth inhibition of human breast cancer cells by 1,25-dihydroxyvitamin D3 is accompanied by induction of apolipoprotein D expression. Cancer Res 1997; 57:4091-7.
41. Sarjeant JM, Lawrie A, Kinnear C, Yablonsky S, Leung W, Massaeli H, et al. Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1/2 to the nucleus. Arterioscler Thromb Vasc Biol 2003; 23:2172-7.
42. Sasaki Y, Negishi H, Koyama R, Anbo N, Ohori K, Idogawa M, et al. p53 family members regulate the expression of the apolipoprotein D gene. J Biol Chem 2009; 284:872-83.
43. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307-10.
44. Zahn JM, Kim SK. Systems biology of aging in four species. Curr Opin Biotechnol 2007; 18:355-9.
45. de Magalhaes JP, Curado J, Church GM. Metaanalysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics 2009; 25:875-81.
46. Loerch PM, Lu T, Dakin KA, Vann JM, Isaacs A, Geula C, et al. Evolution of the aging brain transcriptome and synaptic regulation. PLoS One 2008; 3:3329.
47. Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 1993; 118:401-15.
48. Walker DW, Muffat J, Rundel C, Benzer S. Overexpression of a Drosophila homolog of apolipoprotein D leads to increased stress resistance and extended lifespan. Curr Biol 2006; 16:674-9.
49. Sanchez D, Lopez-Arias B, Torroja L, Canal I, Wang X, Bastiani MJ, et al. Loss of glial lazarillo, a homolog of apolipoprotein D, reduces lifespan and stress resistance in Drosophila. Curr Biol 2006; 16:680-6.
50. Sanchez D, Ganfornina MD, Torres-Schumann S, Speese SD, Lora JM, Bastiani MJ. Characterization of two novel lipocalins expressed in the Drosophila embryonic nervous system. Int J Dev Biol 2000; 44:349-59.
51. Ganfornina MD, Sanchez D, Pagano A, Tonachini L, Descalzi-Cancedda F, Martinez S. Molecular characterization and developmental expression pattern of the chicken apolipoprotein D gene: implications for the evolution of vertebrate lipocalins. Dev Dyn 2005; 232:191-9.
52. Navarro A, Del Valle E, Tolivia J. Differential expression of apolipoprotein d in human astroglial and oligodendroglial cells. J Histochem Cytochem 2004; 52:1031-6.
53. Sanchez D, Ganfornina MD, Martinez S. Expression pattern of the lipocalin apolipoprotein D during mouse embryogenesis. Mech Dev 2002; 110:225-9.
54. Hull-Thompson J, Muffat J, Sanchez D, Walker DW, Benzer S, Ganfornina MD, et al. Control of metabolic homeostasis by stress signaling is mediated by the lipocalin NLaz. PLoS Genet 2009; 5:1000460.
55. Wang MC, Bohmann D, Jasper H. JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell 2005; 121:115-25.
56. Oh SW, Mukhopadhyay A, Svrzikapa N, Jiang F, Davis RJ, Tissenbaum HA. JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16. Proc Natl Acad Sci USA 2005; 102:4494-9.
57. Ganfornina MD, Do Carmo S, Lora JM, Torres-Schumann S, Vogel M, Allhorn M, et al. Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress. Aging Cell 2008; 7:506-15.
58. Charron JB, Ouellet F, Houde M, Sarhan F. The plant Apolipoprotein D ortholog protects Arabidopsis against oxidative stress. BMC Plant Biol 2008; 8:86.
59. Charron JB, Ouellet F, Pelletier M, Danyluk J, Chauve C, Sarhan F. Identification, expression and evolutionary analyses of plant lipocalins. Plant Physiol 2005; 139:2017-28.
60. Muffat J, Walker DW, Benzer S. Human ApoD, an apolipoprotein upregulated in neurodegenerative diseases, extends lifespan and increases stress resistance in Drosophila. Proc Natl Acad Sci USA 2008; 105:7088-93.
61. Frenette Charron JB, Breton G, Badawi M, Sarhan F. Molecular and structural analyses of a novel temperature stress-induced lipocalin from wheat and Arabidopsis. FEBS Lett 2002; 517:129-32.
62. Do Carmo S, Levros LC Jr, Rassart E. Modulation of apolipoprotein D expression and translocation under specific stress conditions. Biochim Biophys Acta 2007; 1773:954-69.
63. Do Carmo S, Jacomy H, Talbot PJ, Rassart E. Neuroprotective effect of apolipoprotein D against human coronavirus OC43-induced encephalitis in mice. J Neurosci 2008; 28:10330-8.
64. Russell SJ, Kahn CR. Endocrine regulation of ageing. Nat Rev Mol Cell Biol 2007; 8:681-91.
65. Do Carmo S, Fournier D, Mounier C, Rassart E. Human apolipoprotein D overexpression in transgenic mice induces insulin resistance and alters lipid metabolism. Am J Physiol Endocrinol Metab 2009; 296:802-11.
66. Vogt M, Skerra A. Construction of an artificial receptor protein ("anticalin") based on the human apolipoprotein D. Chembiochem 2004; 5:191-9.